tradingkey.logo

Balchem Corp

BCPC

156.220USD

+3.600+2.36%
Market hours ETQuotes delayed by 15 min
5.07BMarket Cap
35.52P/E TTM

Balchem Corp

156.220

+3.600+2.36%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated2025-09-17

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
5 / 72
Overall Ranking
80 / 4723
Industry
Chemicals

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 2 analysts
Buy
Current Rating
200.333
Target Price
+30.57%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 21.93.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 22.16%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.16%.
Undervalued
The company’s latest PB is 3.91, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 29.83M shares, decreasing 1.90% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 3.89M shares of this stock.

Financial Health

Currency: USD Updated2025-09-17

The company's current financial score is 9.08, which is higher than the Chemicals industry's average of 7.38. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 255.47M, representing a year-over-year increase of 9.14%, while its net profit experienced a year-over-year increase of 19.36%.

Score

Industry at a Glance

Previous score
9.00
Change
0.08

Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

8.46

Operational Efficiency

8.65

Growth Potential

9.18

Shareholder Returns

9.13

Company Valuation

Currency: USD Updated2025-09-17

The company’s current valuation score is 4.00, which is lower than the Chemicals industry's average of 4.21. Its current P/E ratio is 34.63, which is 24.90% below the recent high of 43.25 and -13.73% above the recent low of 39.38.

Score

Industry at a Glance

Previous score
4.00
Change
0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 5/72
No Data

Earnings Forecast

Currency: USD Updated2025-09-17

The company’s current earnings forecast score is 8.00, which is higher than the Chemicals industry's average of 7.27. The average price target for Balchem Corp is 192.00, with a high of 220.00 and a low of 189.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts
Buy
Current Rating
200.333
Target Price
+30.57%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

45
Total
3
Median
6
Average
Company name
Ratings
Analysts
Balchem Corp
BCPC
2
Apple Inc
AAPL
49
GE Vernova Inc
GEV
34
Avantor Inc
AVTR
23
Tapestry Inc
TPR
21
Verisk Analytics Inc
VRSK
19
1
2
3
...
9

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated2025-09-17

The company’s current price momentum score is 6.39, which is lower than the Chemicals industry's average of 6.85. Sideways: Currently, the stock price is trading between the resistance level at 162.02 and the support level at 147.66, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.42
Change
-0.03

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-2.164
Sell
RSI(14)
35.909
Neutral
STOCH(KDJ)(9,3,3)
7.697
Oversold
ATR(14)
3.160
High Vlolatility
CCI(14)
-135.557
Sell
Williams %R
95.526
Oversold
TRIX(12,20)
-0.071
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
155.262
Buy
MA10
157.506
Sell
MA20
159.830
Sell
MA50
157.926
Sell
MA100
160.564
Sell
MA200
162.899
Sell

Institutional Confidence

Currency: USD Updated2025-09-17

The company’s current institutional recognition score is 10.00, which is higher than the Chemicals industry's average of 7.92. The latest institutional shareholding proportion is 91.92%, representing a quarter-over-quarter increase of 0.69%. The largest institutional shareholder is The Vanguard, holding a total of 3.89M shares, representing 11.99% of shares outstanding, with 1.46% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
4.55M
-2.52%
The Vanguard Group, Inc.
Star Investors
3.84M
-2.82%
State Street Global Advisors (US)
1.23M
-3.76%
Conestoga Capital Advisors, LLC
1.17M
-0.72%
Geode Capital Management, L.L.C.
966.63K
+3.00%
Wasatch Global Investors Inc
Star Investors
1.07M
-11.09%
Geneva Capital Management LLC
830.81K
+1.35%
Dimensional Fund Advisors, L.P.
593.75K
-6.05%
Norges Bank Investment Management (NBIM)
430.48K
+11.10%
Fidelity Management & Research Company LLC
439.55K
+17.55%
1
2

Risk Assessment

Currency: USD Updated2025-09-17

The company’s current risk assessment score is 6.13, which is higher than the Chemicals industry's average of 4.13. The company's beta value is 0.94. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
6.13
Change
0
Beta vs S&P 500 index
0.94
VaR
+2.43%
240-Day Maximum Drawdown
+18.86%
240-Day Volatility
+29.03%
Return
Best Daily Return
60 days
+2.43%
120 days
+6.07%
5 years
+8.40%
Worst Daily Return
60 days
-3.49%
120 days
-4.27%
5 years
-6.95%
Sharpe Ratio
60 days
-0.76
120 days
-0.53
5 years
+0.48
Risk Assessment
Maximum Drawdown
240 days
+18.86%
3 years
+19.37%
5 years
+34.14%
Return-to-Drawdown Ratio
240 days
-0.68
3 years
+0.17
5 years
+0.28
Skewness
240 days
+0.40
3 years
+0.18
5 years
+0.18
Volatility
Realised Volatility
240 days
+29.03%
5 years
+27.23%
Standardised True Range
240 days
+2.42%
5 years
+2.16%
Downside Risk-Adjusted Return
120 days
-81.69%
240 days
-81.69%
Maximum Daily Upside Volatility
60 days
+14.71%
Maximum Daily Downside Volatility
60 days
+14.56%
Liquidity
Average Turnover Rate
60 days
+0.52%
120 days
+0.55%
5 years
--
Turnover Deviation
20 days
+24.31%
60 days
+31.03%
120 days
+37.07%

Peer Comparison

Chemicals
Balchem Corp
Balchem Corp
BCPC
7.36 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Element Solutions Inc
Element Solutions Inc
ESI
7.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Koppers Holdings Inc
Koppers Holdings Inc
KOP
7.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Linde PLC
Linde PLC
LIN
7.38 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Mosaic Co
Mosaic Co
MOS
7.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Flexible Solutions International Inc
Flexible Solutions International Inc
FSI
7.31 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI